Published in Biomaterials on May 15, 2010
Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity. Int J Mol Sci (2014) 0.95
Regulation of substituent groups on morphologies and self-assembly of organogels based on some azobenzene imide derivatives. Nanoscale Res Lett (2013) 0.91
Self-assembly of organogels via new luminol imide derivatives: diverse nanostructures and substituent chain effect. Nanoscale Res Lett (2013) 0.88
Spacer effect on nanostructures and self-assembly in organogels via some bolaform cholesteryl imide derivatives with different spacers. Nanoscale Res Lett (2013) 0.82
Rivastigmine-loaded L-lactide-depsipeptide polymeric nanoparticles: decisive formulation variable optimization. Sci Pharm (2013) 0.80
A Peptide Amphiphile Organogelator of Polar Organic Solvents. Sci Rep (2017) 0.75
Self-Assembly and Drug Release Capacities of Organogels via Some Amide Compounds with Aromatic Substituent Headgroups. Materials (Basel) (2016) 0.75
A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol (1961) 45.34
Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature (1998) 3.46
Hippocampal system and declarative (relational) memory: summarizing the data from functional neuroimaging studies. Hippocampus (1999) 2.14
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule. Int J Geriatr Psychiatry (2007) 1.92
A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging (2008) 1.61
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease. Int J Geriatr Psychiatry (2007) 1.38
Organogels and their use in drug delivery--a review. J Control Release (2007) 1.30
A comparison and evaluation of the predictions of relational and conjunctive accounts of hippocampal function. Hippocampus (2006) 1.28
A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm (2004) 1.23
Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review. Int J Clin Pract (2009) 1.19
Pharmacokinetic rationale for the rivastigmine patch. Neurology (2007) 1.11
New biodegradable polymers for injectable drug delivery systems. J Control Release (1999) 1.07
Organogels as scaffolds for excitation energy transfer and light harvesting. Chem Soc Rev (2007) 1.05
Rivastigmine in the treatment of Alzheimer's disease: an update. Clin Interv Aging (2007) 0.97
Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. J Manag Care Pharm (2005) 0.95
Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride. AAPS PharmSciTech (2004) 0.93
Topical delivery of aceclofenac from lecithin organogels: preformulation study. Curr Drug Deliv (2006) 0.92
A review of rivastigmine: a reversible cholinesterase inhibitor. Clin Ther (2003) 0.91
In situ-forming oleogel implant for rivastigmine delivery. Pharm Res (2007) 0.91
Sorbitan ester organogels for transdermal delivery of sumatriptan. Drug Dev Ind Pharm (2007) 0.86
In situ-forming pharmaceutical organogels based on the self-assembly of L-alanine derivatives. Pharm Res (2004) 0.86
Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J Microencapsul (2005) 0.86
Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol. Int J Pharm (2006) 0.86
Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm (2006) 0.86
Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharm Res (2002) 0.85
Analgesic efficacy of a lecithin-vehiculated diclofenac epolamine gel in shoulder periarthritis and lateral epicondylitis: a placebo-controlled, multicenter, randomized, double-blind clinical trial. Drugs Exp Clin Res (2005) 0.84
Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement. Drug Deliv (2003) 0.83
First report on the efficacy of l-alanine-based in situ-forming implants for the long-term parenteral delivery of drugs. J Control Release (2005) 0.83
Double-blind, randomized, controlled study on the efficacy and safety of a novel diclofenac epolamine gel formulated with lecithin for the treatment of sprains, strains and contusions. Drugs Exp Clin Res (2003) 0.83
Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: in vivo evaluation. Pharm Res (1995) 0.82
Characterization and biocompatibility of organogels based on L-alanine for parenteral drug delivery implants. Biomaterials (2005) 0.81
In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease. Biomaterials (2006) 0.80
Preparation and characterization of reverse micelle based organogels of piroxicam. Pharmazie (2004) 0.80
Adherence to cholinesterase inhibitors in patients with Alzheimer's disease. J Am Geriatr Soc (2009) 0.79
Subchronic feeding study in beagle dogs of N-methylpyrrolidone. J Appl Toxicol (1983) 0.79
Controlled release tacrine delivery system for the treatment of Alzheimer's disease. Drug Deliv (2001) 0.79
Genomic and transcriptional characterization of the human ACHE locus: complex involvement with acquired and inherited diseases. Isr Med Assoc J (2000) 0.79
Periprandial systemic and regional lipase activity in normal humans. Am J Physiol (1996) 0.79
In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid). Chem Pharm Bull (Tokyo) (2006) 0.78
Physicochemical characterization of bioactive polyacrylic acid organogels as potential antimicrobial implants for the buccal cavity. Biomacromolecules (2008) 0.77
Morphine bioavailability from a topical gel formulation in volunteers. J Pain Symptom Manage (2008) 0.77
Controlled release of huperzine A from biodegradable microspheres: In vitro and in vivo studies. Int J Pharm (2006) 0.77
Sorbitan monostearate/polysorbate 20 organogels containing niosomes: a delivery vehicle for antigens? Eur J Pharm Sci (1999) 0.77
Novel gels and their dispersions--oral drug delivery systems for ciclosporin. Int J Pharm (2005) 0.76
Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release (2005) 2.79
In situ-forming hydrogels--review of temperature-sensitive systems. Eur J Pharm Biopharm (2004) 2.08
Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol (2002) 2.03
Psychosis pathways converge via D2high dopamine receptors. Synapse (2006) 1.78
Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res (2010) 1.43
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev (2002) 1.41
Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br J Pharmacol (2004) 1.35
Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival. J Neurochem (2004) 1.33
The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release (2011) 1.32
Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J Control Release (2009) 1.31
Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol (2007) 1.31
Organogels and their use in drug delivery--a review. J Control Release (2007) 1.30
A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm (2004) 1.23
A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) (2003) 1.23
Use of a PEG-conjugated bright near-infrared dye for functional imaging of rerouting of tumor lymphatic drainage after sentinel lymph node metastasis. Biomaterials (2013) 1.22
Oxytocin-induced analgesia and scratching are mediated by the vasopressin-1A receptor in the mouse. J Neurosci (2010) 1.21
Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur J Neurosci (2006) 1.20
Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules. Adv Drug Deliv Rev (2004) 1.20
FoxO-dependent and -independent mechanisms mediate SirT1 effects on IGFBP-1 gene expression. Biochem Biophys Res Commun (2005) 1.19
FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem (2002) 1.18
Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. J Neurosci (2002) 1.18
Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology (2008) 1.12
A microdialysis profile of Met-enkephalin release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2005) 1.11
Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res (2003) 1.09
Molecular basis of programmed cell death involved in neurodegeneration. Trends Neurosci (2005) 1.09
Stereocomplex block copolymer micelles: core-shell nanostructures with enhanced stability. Nano Lett (2005) 1.08
Apple peel polyphenols and their beneficial actions on oxidative stress and inflammation. PLoS One (2013) 1.08
Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. PLoS One (2012) 1.07
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev (2011) 1.06
Toxicity of silver nanoparticles in macrophages. Small (2013) 1.05
A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res (2006) 1.04
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology (2002) 1.04
Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation. Biomaterials (2011) 1.04
Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets (2007) 1.03
The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. Gastroenterology (2011) 1.03
Polymeric micelles for oral drug delivery. Eur J Pharm Biopharm (2010) 1.02
Estrogen effects on object memory and cholinergic receptors in young and old female mice. Neurobiol Aging (2001) 1.02
A possible role of neuropeptide Y in depression and stress. Brain Res (2009) 1.02
Characterization of the membrane-destabilizing properties of different pH-sensitive methacrylic acid copolymers. Biochim Biophys Acta (2003) 1.01
Dynamics of lymphatic regeneration and flow patterns after lymph node dissection. Breast Cancer Res Treat (2013) 1.01
Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA. J Neurosci (2004) 1.01
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials (2007) 1.00
Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol (2002) 0.99
Magnetic nanoparticles encapsulated into biodegradable microparticles steered with an upgraded magnetic resonance imaging system for tumor chemoembolization. Biomaterials (2009) 0.99
Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neurosci (2006) 0.99
Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264.7 macrophage cell line. Immunology (2010) 0.99
Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice. Neurobiol Dis (2009) 0.98
Biomedical applications of bisphosphonates. J Control Release (2013) 0.98
Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials (2002) 0.98
Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm Res (2006) 0.98
Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles. Biomacromolecules (2007) 0.97
cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease. Pharmacol Ther (2003) 0.97
Does COX2-dependent PGE2 play a role in neuropathic pain? Neurosci Lett (2008) 0.96
Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. Biomacromolecules (2009) 0.96
Kinetic characterization and identification of the acylation and glycosylation sites of recombinant human gamma-glutamyltranspeptidase. Biochemistry (2007) 0.96
pH-responsive polymeric micelles of poly(ethylene glycol)-b-poly(alkyl(meth)acrylate-co-methacrylic acid): influence of the copolymer composition on self-assembling properties and release of candesartan cilexetil. Eur J Pharm Biopharm (2006) 0.96
Glutamate acting on N-methyl-D-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J Biol Chem (2008) 0.95
Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells. Br J Pharmacol (2003) 0.95
α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling. J Neurochem (2011) 0.95
Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci (2002) 0.95
Characterization of neuropeptide Y, Y(2) receptor knockout mice in two animal models of learning and memory processing. J Mol Neurosci (2004) 0.95
Treatment of calcium channel blocker-induced cardiovascular toxicity with drug scavenging liposomes. Biomaterials (2012) 0.94
Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging (2007) 0.94
Sustained gastrointestinal activity of dendronized polymer-enzyme conjugates. Nat Chem (2013) 0.93
A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers. Pharm Res (2004) 0.93
Morphological reorganization after repeated corticosterone administration in the hippocampus, nucleus accumbens and amygdala in the rat. J Chem Neuroanat (2009) 0.92
In vivo fluorescence imaging of exogenous enzyme activity in the gastrointestinal tract. Proc Natl Acad Sci U S A (2011) 0.92
Natural extracts as possible protective agents of brain aging. Neurobiol Aging (2002) 0.92
Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites. PLoS One (2010) 0.92
In situ-forming oleogel implant for rivastigmine delivery. Pharm Res (2007) 0.91
Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease. Eur J Neurosci (2013) 0.91
Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther (2006) 0.90
Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice. Cancer Res (2012) 0.90
Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. J Control Release (2004) 0.90
Brain targeting using novel lipid nanovectors. J Control Release (2007) 0.90
Enhancement of docetaxel solubility via conjugation of formulation-compatible moieties. Org Biomol Chem (2009) 0.89
Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3k/Akt pathway. J Neurosci Res (2004) 0.89
Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes. J Control Release (2004) 0.89
Effect of Mas-related gene (Mrg) receptors on hyperalgesia in rats with CFA-induced inflammation via direct and indirect mechanisms. Br J Pharmacol (2013) 0.89
Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo. Angiogenesis (2013) 0.89
Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety- and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity. J Mol Neurosci (2009) 0.89
Nanonization of megestrol acetate by laser fragmentation in aqueous milieu. J Control Release (2010) 0.88
Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. J Alzheimers Dis (2012) 0.88
Modulation of NMDA receptors by intrathecal administration of the sensory neuron-specific receptor agonist BAM8-22. Neuropharmacology (2007) 0.88
Targeting bacterial toxins. Angew Chem Int Ed Engl (2012) 0.88